Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CONMED Co. stock logo
CNMD
CONMED
$59.40
-1.6%
$63.40
$55.22
$80.65
$1.84B1.53452,545 shs339,066 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CONMED Co. stock logo
CNMD
CONMED
-1.99%-0.51%+0.52%-13.22%-24.81%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CONMED Co. stock logo
CNMD
CONMED
4.6159 of 5 stars
3.31.02.54.32.10.83.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CONMED Co. stock logo
CNMD
CONMED
2.60
Moderate Buy$77.2029.98% Upside

Current Analyst Ratings Breakdown

Latest CNMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/6/2025
CONMED Co. stock logo
CNMD
CONMED
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$72.00 ➝ $75.00
2/6/2025
CONMED Co. stock logo
CNMD
CONMED
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$74.00 ➝ $70.00
2/6/2025
CONMED Co. stock logo
CNMD
CONMED
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$97.00 ➝ $91.00
2/6/2025
CONMED Co. stock logo
CNMD
CONMED
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$85.00 ➝ $70.00
(Data available from 4/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CONMED Co. stock logo
CNMD
CONMED
$1.31B1.40$6.51 per share9.13$31.15 per share1.91
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CONMED Co. stock logo
CNMD
CONMED
$132.42M$4.2414.0111.711.8310.13%14.31%5.64%4/23/2025 (Estimated)

Latest CNMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/23/2025N/A
CONMED Co. stock logo
CNMD
CONMED
$0.81N/AN/AN/A$313.38 millionN/A
2/5/2025Q4 2024
CONMED Co. stock logo
CNMD
CONMED
$1.20$1.34+$0.14$1.08$341.05 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CONMED Co. stock logo
CNMD
CONMED
$0.801.35%N/A18.87%N/A

Latest CNMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/24/2025
CONMED Co. stock logo
CNMD
CONMED
quarterly$0.201.29%3/14/20253/14/20254/4/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CONMED Co. stock logo
CNMD
CONMED
0.94
2.30
1.06

Institutional Ownership

CompanyInstitutional Ownership
CONMED Co. stock logo
CNMD
CONMED
N/A

Insider Ownership

CompanyInsider Ownership
CONMED Co. stock logo
CNMD
CONMED
6.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
CONMED Co. stock logo
CNMD
CONMED
4,10030.91 million28.81 millionOptionable

Recent News About These Companies

RSI Alert: CONMED Now Oversold

New MarketBeat Followers Over Time

Media Sentiment Over Time

CONMED stock logo

CONMED NYSE:CNMD

$59.40 -1.00 (-1.65%)
Closing price 04/1/2025 03:59 PM Eastern
Extended Trading
$59.40 +0.00 (+0.01%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.